Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.
(Photo: Company Website) Global pharma major Lupin Limited on Monday announced its focus on formulating respiratory inhalers by incorporating a propellant with near-zero global warming potential ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA ...